Annual Cash & Cash Equivalents
$4.23 M
-$730.60 K-14.72%
September 1, 2024
Summary
- As of February 12, 2025, DRUG annual cash & cash equivalents is $4.23 million, with the most recent change of -$730.60 thousand (-14.72%) on September 1, 2024.
- During the last 3 years, DRUG annual cash & cash equivalents has fallen by -$11.26 million (-72.67%).
- DRUG annual cash & cash equivalents is now -72.67% below its all-time high of $15.49 million, reached on September 30, 2021.
Performance
DRUG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.23 M
-$285.70 K-6.32%
September 1, 2024
Summary
- As of February 12, 2025, DRUG quarterly cash and cash equivalents is $4.23 million, with the most recent change of -$285.70 thousand (-6.32%) on September 1, 2024.
- Over the past year, DRUG quarterly cash and cash equivalents has dropped by -$863.30 thousand (-16.94%).
- DRUG quarterly cash and cash equivalents is now -79.00% below its all-time high of $20.16 million, reached on March 31, 2021.
Performance
DRUG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DRUG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.7% | -16.9% |
| 3 y3 years | -72.7% | -16.9% |
| 5 y5 years | +608.5% | -16.9% |
DRUG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.7% | at low | -64.3% | at low |
| 5 y | 5-year | -72.7% | +608.5% | -79.0% | +608.5% |
| alltime | all time | -72.7% | +608.5% | -79.0% | +608.5% |
Bright Minds Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $4.23 M(-14.7%) | $4.23 M(-6.3%) |
| Jun 2024 | - | $4.52 M(+2.9%) |
| Mar 2024 | - | $4.39 M(-13.9%) |
| Dec 2023 | - | $5.10 M(+2.7%) |
| Sep 2023 | $4.96 M(-41.6%) | $4.96 M(-19.1%) |
| Jun 2023 | - | $6.14 M(-14.2%) |
| Mar 2023 | - | $7.15 M(-13.4%) |
| Dec 2022 | - | $8.26 M(-2.8%) |
| Sep 2022 | $8.50 M | $8.50 M(+26.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $6.71 M(-27.0%) |
| Mar 2022 | - | $9.19 M(-22.5%) |
| Dec 2021 | - | $11.86 M(-23.5%) |
| Sep 2021 | $15.49 M(+2492.3%) | - |
| Sep 2021 | - | $15.49 M(-12.7%) |
| Jun 2021 | - | $17.75 M(-12.0%) |
| Mar 2021 | - | $20.16 M(+1145.1%) |
| Dec 2020 | - | $1.62 M(+171.0%) |
| Sep 2020 | $597.60 K | - |
| Sep 2020 | - | $597.60 K |
FAQ
- What is Bright Minds Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual cash & cash equivalents year-on-year change?
- What is Bright Minds Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly cash and cash equivalents year-on-year change?
What is Bright Minds Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of DRUG is $4.23 M
What is the all time high annual cash & cash equivalents for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual cash & cash equivalents is $15.49 M
What is Bright Minds Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, DRUG annual cash & cash equivalents has changed by -$730.60 K (-14.72%)
What is Bright Minds Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DRUG is $4.23 M
What is the all time high quarterly cash and cash equivalents for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly cash and cash equivalents is $20.16 M
What is Bright Minds Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, DRUG quarterly cash and cash equivalents has changed by -$863.30 K (-16.94%)